WELCOME to: 'Stu's Views and MS News' an informational archive provided by MS Views and News

· Key-Note: This blog provides education, information and resources to benefit those affected by Multiple Sclerosis.

· Opt-In at our website (MS Views and News) to receive our globally transmitted Multiple Sclerosis e-newsletter, currently being received in more than (90) Countries.

· Our live MS educational seminars average 67 people per educational program. SINCE our first program in February 2010, we have hosted more than 130 educational programs.

· Visit our Multiple Sclerosis Learning channel on YouTube archived by topic here: www.youtube.com/msviewsandnews

Be Empowered with Beneficial MS Information - ---Visit MS Views and News.org

joomla ecommerce template

View all the resources found on the left side of this blog. Use our 'search by topic' tool, when wanting to find specificinformation.

==================================================================

Tuesday, September 22, 2009

FDA confirms 3 new infections linked to Tysabri

FDA confirms 3 new infections linked to Tysabri

NEW YORK — The Food and Drug Administration says it confirmed three new cases of a potentially lethal brain inflammation linked to the multiple sclerosis drug Tysabri.

There have been 13 reported cases of progressive multifocal leukoencephalopathy, or PML, since mid-2006. The reports are the first confirmed new cases since June. While the disease is rare, the FDA says the risk appears to increase as patients remain on Tysabri.

Tysabri is marketed by Biogen Idec Inc. and Elan Corp. PLC, for multiple sclerosis and Crohn's disease. All the PML cases are linked to its use in multiple sclerosis.

The drug was approved in November 2004 and pulled from the market the next year due to PML reports. It was reintroduced in July 2006, and Biogen said it is used by 43,000 patients.

============================================

No comments: